US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Nov 13, 2025 (10 months ago)

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

What was recalled

Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
70748-274-01
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0220-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ganirelix recalls

See all